[1]
‘Efficacy of Cholecalciferol In The Management Of Secondary Hyperparathyroidism In Hemodialysis Patients’., Pak J Kidney Dis, vol. 4, nr. 1, jan. 2020, doi: 10.53778/pjkd4181.